Intchains Group
ICG
BIGG DIGITAL ASSETS INC
BBKCF
NEPTUNE DIGITAL ASSETS CORP
NPPTF
Bitdeer Technologies
BTDR
FRMO CORP
FRMO
US Stock MarketDetailed Quotes
AGIO Agios Pharmaceuticals
- 35.420
- -0.390-1.09%
Close Dec 20 16:00 ET
- 35.420
- 0.0000.00%
Post 20:01 ET
2.02BMarket Cap3.04P/E (TTM)
36.300High35.130Low3.20MVolume35.500Open35.810Pre Close113.49MTurnover6.33%Turnover RatioLossP/E (Static)57.03MShares62.58052wk High1.24P/B1.79BFloat Cap20.96052wk Low--Dividend TTM50.52MShs Float138.850Historical High--Div YieldTTM3.27%Amplitude15.770Historical Low35.475Avg Price1Lot Size
About Agios Pharmaceuticals Company
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.
Company Profile
SymbolAGIO
Company NameAgios Pharmaceuticals
Listing DateJul 24, 2013
Issue Price18.00
Founded2007
CEOMr. Brian Goff
MarketNASDAQ
Employees386
Fiscal Year Ends12-31
Address88 Sidney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139-4169
Phone1-617-649-8600
Websitehttp://www.agios.com
Company Executives
- Name
- Position
- Salary
- Brian Goff
- Chief Executive Officer and Director
- 3.42M
- James William Burns
- Chief Legal Officer
- 1.93M
- Dr. Sarah Gheuens, M.D.,PhD
- Chief Medical Officer and Head of Research and Development
- 2.87M
- Tsveta Milanova
- Chief Commercial Officer
- 3.73M
- Cecilia Jones
- Chief Financial Officer
- 1.21M
- T. J. Washburn
- Principal Accounting Officer, Vice President and Controller
- --
- Dr. Jacqualyn A. Fouse, PhD
- Chairman of the Board
- 447.25K
- Jeffrey D. Capello
- Independent Director
- 663.68K
- Dr. David T. Scadden, M.D.
- Independent Director
- 429.75K
- Dr. Rahul D. Ballal, PhD
- Independent Director
- 427.25K
- Dr. Maykin Ho, PhD
- Independent Director
- 424.75K
- Cynthia Smith
- Independent Director
- 419.91K
- Dr. David P. Schenkein, M.D.
- Independent Director
- 417.25K
- Catherine Owen
- Independent Director
- 659.94K
- Kaye Foster
- Lead Independent Director
- 440.95K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.